Page last updated: 2024-09-03

nitroaspirin and vorapaxar

nitroaspirin has been researched along with vorapaxar in 1 studies

Compound Research Comparison

Studies (nitroaspirin)	Trials (nitroaspirin)	Recent Studies (post-2010) (nitroaspirin)	Studies (vorapaxar)	Trials (vorapaxar)	Recent Studies (post-2010) (vorapaxar)
127	9	8	225	57	187

Protein Interaction Comparison

Protein	Taxonomy	nitroaspirin (IC50)	vorapaxar (IC50)
Proteinase-activated receptor 1	Homo sapiens (human)		0.0626

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Butt, M; Lip, GY; Shantsila, E; Siddique, A	1

Reviews

1 review(s) available for nitroaspirin and vorapaxar

Article	Year
New antiplatelet drugs: beyond aspirin and clopidogrel. International journal of clinical practice, 2009, Volume: 63, Issue:5 Topics: Adenosine; Adenosine Monophosphate; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Artery Disease; Drug Design; Humans; Imines; Lactones; Naphthalenes; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Propionates; Purinergic P2 Receptor Antagonists; Pyridines; Thiophenes; Ticagrelor; Ticlopidine	2009

Article

Year

New antiplatelet drugs: beyond aspirin and clopidogrel.

International journal of clinical practice, 2009, Volume: 63, Issue:5

Topics: Adenosine; Adenosine Monophosphate; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Artery Disease; Drug Design; Humans; Imines; Lactones; Naphthalenes; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Propionates; Purinergic P2 Receptor Antagonists; Pyridines; Thiophenes; Ticagrelor; Ticlopidine

2009